09/14/2022
Something that many people are often not aware of is that childhood cancers do not act like adult cancers, they are not the same and must be treated differently.
One of the major keys to beating childhood cancer is researching and developing better drugs that are specifically designed for children, teenager & young adult's developing bodies that leave healthy cells alone while destroying cancerous cells.
While hundreds of cancer drugs have been developed and approved for adults, the FDA, up to and including 2020 has approved a total of 34 drugs for use in the treatment of childhood cancers.
However, 28 of those 34 drugs were originally approved for adult use only. That's right, an infant, toddler or teenager can get a chemotherapy drug that was originally designed and approved for an adult. Many of the adult drugs now being used for children cause severe late term side effects. Some of those that are routinely used like Methotrexate and Cyclophosphamide were approved over 60 years old. Vincristine, which is also widely used, was approved in 1963.
What chance do our kids have when they are up against such archaic treatments?
Survivors of any kind of cancer can develop health problems months or years after cancer treatment, these are known as late effects, but late effects are of particular concern for childhood cancer survivors because treatment of children can lead to profound, lasting physical and emotional effects.
Today, we have six drugs in use that were approved in the "first instance" for use in cancer treatment for children, they are;
*Teniposide (1992 for ALL) now discontinued and not in use
*Clofarabine (2004 for ALL).
*Dinutuximab (2015 for NB).
*Tisagenlecleucel (2017 for ALL).
*Calaspargase pegol-mk (2018 for ALL).
*Selumetinib (2020 for NF1).
*Naxitamab (2020 for NB).
These are the ONLY drugs that have EVER been developed and approved for use in the first instance for children.
Yes, EVER
EVER EVER EVER
In the whole history of cancer drug research, clinical trial and FDA approval
We are sure more are in the pipeline, but......
We desperately need to develop more drugs specifically for children that will not have such life-altering consequences.
Awareness is key
It's where we start.....